ELCC 2017 European Lung Cancer Conference

Our clinics poster titled “Response to Metabolically Supported Chemotherapy (MSCT) with weekly Carboplatin/Paclitaxel in Advanced Stage / Metastatic (Stage IV) Non-Small Cell Lung Cancer: A Survival, Efficacy and Tolerability Analysis ” was accepted to be presented at the ELCC 2017 European Lung Cancer Conference.

We will be attending the conference that will take place at 5-8 May 2017, in Geneva, Switzerland. At the conference we will be presenting the poster of our upcoming publication on our treatment outcomes with our Stage IV NSCLC patients where we will be reporting the best treatment outcomes and longest mean survival time worldwide!

ELCC 2017 Abstract